Bell D - Search Results

1

Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancer.

FitzGerald MG, Marsh DJ, Wahrer D, Bell D, Caron S, Shannon KE, Ishioka C, Isselbacher KJ, Garber JE, Eng C, Haber DA. FitzGerald MG, et al. Among authors: bell d. Oncogene. 1998 Aug 13;17(6):727-31. doi: 10.1038/sj.onc.1201984. Oncogene. 1998. PMID: 9715274

2

Common nonsense mutations in RAD52.

Bell DW, Wahrer DC, Kang DH, MacMahon MS, FitzGerald MG, Ishioka C, Isselbacher KJ, Krainer M, Haber DA. Bell DW, et al. Cancer Res. 1999 Aug 15;59(16):3883-8. Cancer Res. 1999. PMID: 10463575

3

Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease.

Nichols KE, Levitz S, Shannon KE, Wahrer DC, Bell DW, Chang G, Hegde S, Neuberg D, Shafman T, Tarbell NJ, Mauch P, Ishioka C, Haber DA, Diller L. Nichols KE, et al. Among authors: bell dw. J Clin Oncol. 1999 Apr;17(4):1259. doi: 10.1200/JCO.1999.17.4.1259. J Clin Oncol. 1999. PMID: 10561187

4

Selective loss of heterozygosity in multiple breast cancers from a carrier of mutations in both BRCA1 and BRCA2.

Bell DW, Erban J, Sgroi DC, Haber DA. Bell DW, et al. Cancer Res. 2002 May 15;62(10):2741-3. Cancer Res. 2002. PMID: 12019146

5

Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancer.

Kwak EL, Moberg KH, Wahrer DC, Quinn JE, Gilmore PM, Graham CA, Hariharan IK, Harkin DP, Haber DA, Bell DW. Kwak EL, et al. Among authors: bell dw. Gynecol Oncol. 2005 Jul;98(1):124-8. doi: 10.1016/j.ygyno.2005.04.007. Gynecol Oncol. 2005. PMID: 15913747

6

Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts.

Bell DW, Kim SH, Godwin AK, Schiripo TA, Harris PL, Haserlat SM, Wahrer DC, Haiman CA, Daly MB, Niendorf KB, Smith MR, Sgroi DC, Garber JE, Olopade OI, Le Marchand L, Henderson BE, Altshuler D, Haber DA, Freedman ML. Bell DW, et al. Int J Cancer. 2007 Dec 15;121(12):2661-7. doi: 10.1002/ijc.23026. Int J Cancer. 2007. PMID: 17721994 Free PMC article.

7

Prevalence and functional analysis of sequence variants in the ATR checkpoint mediator Claspin.

Zhang J, Song YH, Brannigan BW, Wahrer DC, Schiripo TA, Harris PL, Haserlat SM, Ulkus LE, Shannon KM, Garber JE, Freedman ML, Henderson BE, Zou L, Sgroi DC, Haber DA, Bell DW. Zhang J, et al. Mol Cancer Res. 2009 Sep;7(9):1510-6. doi: 10.1158/1541-7786.MCR-09-0033. Epub 2009 Sep 8. Mol Cancer Res. 2009. PMID: 19737971 Free PMC article.

8

Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles.

Chaudhuri S, Cariappa A, Tang M, Bell D, Haber DA, Isselbacher KJ, Finkelstein D, Forcione D, Pillai S. Chaudhuri S, et al. Among authors: bell d. Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11451-4. doi: 10.1073/pnas.97.21.11451. Proc Natl Acad Sci U S A. 2000. PMID: 11027344 Free PMC article.

9

Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor.

Shafman TD, Levitz S, Nixon AJ, Gibans LA, Nichols KE, Bell DW, Ishioka C, Isselbacher KJ, Gelman R, Garber J, Harris JR, Haber DA. Shafman TD, et al. Among authors: bell dw. Genes Chromosomes Cancer. 2000 Feb;27(2):124-9. Genes Chromosomes Cancer. 2000. PMID: 10612799

10

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.

Bell DW, Varley JM, Szydlo TE, Kang DH, Wahrer DC, Shannon KE, Lubratovich M, Verselis SJ, Isselbacher KJ, Fraumeni JF, Birch JM, Li FP, Garber JE, Haber DA. Bell DW, et al. Science. 1999 Dec 24;286(5449):2528-31. doi: 10.1126/science.286.5449.2528. Science. 1999. PMID: 10617473

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,700 results

Search Page